- Investing Ideas
- Software Healthcare Sector
Software Healthcare Sector
Results
2169
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2169 companies
LeonaBio
Market Cap: US$72.4m
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis.
LONA
US$7.73
7D
-5.4%
1Y
90.9%
Forum Markets
Market Cap: US$72.3m
A financial technology company, develops a blockchain-based platform focused on the acquisition, structuring, and tokenization of real-world assets worldwide.
FRMM
US$6.03
7D
2.4%
1Y
-80.4%
Pliant Therapeutics
Market Cap: US$71.5m
A clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors.
PLRX
US$1.14
7D
3.6%
1Y
-23.5%
PMV Pharmaceuticals
Market Cap: US$71.1m
A precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.
PMVP
US$1.31
7D
4.4%
1Y
-8.1%
Spero Therapeutics
Market Cap: US$71.0m
A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.
SPRO
US$1.22
7D
2.1%
1Y
-34.3%
iBio
Market Cap: US$71.0m
A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space.
IBIO
US$1.42
7D
-2.1%
1Y
67.9%
MDxHealth
Market Cap: US$70.9m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$0.74
7D
-13.4%
1Y
-79.1%
Rein Therapeutics
Market Cap: US$70.6m
A biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.
RNTX
US$0.80
7D
-4.9%
1Y
-32.2%
XBiotech
Market Cap: US$69.5m
A biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases.
XBIT
US$2.31
7D
0%
1Y
-27.8%
NOMAD Power Solutions
Market Cap: US$69.2m
Develops utility-scale mobile energy storage systems on providing transportable solutions.
NMAD
US$4.15
7D
6.4%
1Y
26.1%
Redwood AI
Market Cap: CA$95.5m
Provides artificial intelligence (AI)-based software and analytics solutions for chemical and pharmaceutical development.
AIRX
CA$1.85
7D
-7.5%
1Y
n/a
Champions Oncology
Market Cap: US$68.9m
A technology-enabled research company, provides technology solutions for drug discovery and development in the United States.
CSBR
US$4.97
7D
-1.2%
1Y
-29.6%
Odysight.ai
Market Cap: US$68.8m
Develops, produces, and markets visual monitoring artificial intelligence (AI) solutions in Israel, the United States, and internationally.
ODYS
US$3.68
7D
-5.9%
1Y
1.1%
Shield Therapeutics
Market Cap: UK£50.3m
A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.
STX
UK£0.047
7D
6.8%
1Y
-41.7%
Myomo
Market Cap: US$68.5m
A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.
MYO
US$1.39
7D
-11.5%
1Y
27.5%
Cardiff Oncology
Market Cap: US$68.5m
A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States.
CRDF
US$1.00
7D
10.4%
1Y
-54.8%
MediciNova
Market Cap: US$68.4m
A biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
MNOV
US$1.53
7D
15.9%
1Y
15.9%
Boundless Bio
Market Cap: US$68.2m
A clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers.
BOLD
US$2.96
7D
4.6%
1Y
161.9%
Lumos Diagnostics Holdings
Market Cap: AU$94.4m
Develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States.
LDX
AU$0.10
7D
-9.1%
1Y
-4.8%
eXoZymes
Market Cap: US$66.4m
Operates as a development stage biotechnology company.
EXOZ
US$6.95
7D
15.3%
1Y
-25.3%
MindWalk Holdings
Market Cap: US$66.3m
Operates as a bio-native AI company.
HYFT
US$1.38
7D
3.8%
1Y
-50.0%
Abingdon Health
Market Cap: UK£47.9m
Develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally.
ABDX
UK£0.11
7D
4.8%
1Y
83.3%
LTR Pharma
Market Cap: AU$90.9m
A clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.
LTP
AU$0.49
7D
3.2%
1Y
-9.3%
INmune Bio
Market Cap: US$64.4m
A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.
INMB
US$2.36
7D
10.8%
1Y
5.4%
BioStem Technologies
Market Cap: US$63.2m
Engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States.
BSEM
US$3.92
7D
30.7%
1Y
-31.8%
EDX Medical Group
Market Cap: UK£46.3m
Engages in developing a range of diagnostics testing solutions in the United Kingdom.
EDX
UK£0.11
7D
15.4%
1Y
7.1%
Epiminder
Market Cap: AU$87.6m
Develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions.
EPI
AU$0.41
7D
-2.4%
1Y
n/a
ImageneBio
Market Cap: US$62.5m
A clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases.
IMA
US$5.62
7D
0.7%
1Y
-60.3%
Talphera
Market Cap: US$61.8m
A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.
TLPH
US$1.19
7D
-0.8%
1Y
107.1%
ME Therapeutics Holdings
Market Cap: CA$85.1m
A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.
METX
CA$1.90
7D
11.8%
1Y
-52.5%
hVIVO
Market Cap: UK£44.9m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.065
7D
-0.9%
1Y
-34.6%
MiNK Therapeutics
Market Cap: US$60.8m
A clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.
INKT
US$11.82
7D
5.3%
1Y
-18.9%
Xilio Therapeutics
Market Cap: US$60.7m
A clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies.
XLO
US$9.19
7D
-3.2%
1Y
-6.2%
Heron Therapeutics
Market Cap: US$60.4m
A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
HRTX
US$0.32
7D
0.9%
1Y
-76.6%
Nano-X Imaging
Market Cap: US$59.8m
Develops a commercial-grade tomographic imaging device with a digital X-ray source.
NNOX
US$0.86
7D
-7.4%
1Y
-77.8%
Tian'an Technology Group
Market Cap: US$59.6m
Through its subsidiaries, engages in the research, development, and production of graphene products for the health therapy industry in China.
TANA.F
US$1.04
7D
-35.8%
1Y
-93.1%